Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alto Neuroscience (ANRO) Free Cash Flow (2023 - 2026)

Alto Neuroscience has reported Free Cash Flow over the past 4 years, most recently at -$28.0 million for Q1 2026.

  • Quarterly results put Free Cash Flow at -$28.0 million for Q1 2026, down 69.07% from a year ago — trailing twelve months through Mar 2026 was -$63.2 million (down 15.26% YoY), and the annual figure for FY2025 was -$51.8 million, down 4.63%.
  • Free Cash Flow reached -$28.0 million in Q1 2026 per ANRO's latest filing, down from -$11.5 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at -$6.7 million in Q2 2023 and bottomed at -$28.0 million in Q1 2026.
  • Median Free Cash Flow over the past 4 years was -$12.0 million (2023), compared with a mean of -$12.6 million.
  • The largest annual shift saw Free Cash Flow plummeted 79.91% in 2024 before it grew 22.1% in 2025.
  • Over 4 years, Free Cash Flow stood at -$12.0 million in 2023, then decreased by 12.78% to -$13.5 million in 2024, then rose by 14.87% to -$11.5 million in 2025, then crashed by 143.42% to -$28.0 million in 2026.
  • Business Quant data shows Free Cash Flow for ANRO at -$28.0 million in Q1 2026, -$11.5 million in Q4 2025, and -$9.9 million in Q3 2025.